Evening Memo | Oil relief and short-end yields set market tone for tomorrow
• Stocks slid while rates rose as oil-sanctions relief and short-end bill repricing dominated. • After hours: AbbVie/Apogee deal press page surfaced confirming the cash takeover.
What Moved Today
Market Recap — M&A and geopolitics drove price action: AbbVie agreed to buy Apogee for $135.11/share, repricing biotech risk and takeover spreads ($ABBV, $APGE). Reuters’ report of a temporary U.S. license for Iranian oil reduced risk premia and sent Brent and futures lower ($CL=F, $BZ=F). Front-end Treasury bill yields jumped at large auctions, tightening cash-market dynamics and nudging short-duration ETFs ($BIL, $SHY).
Intraday — From the open, the AbbVie/Apogee announcement set takeover headlines while Reuters’ 60-day Iran oil license knocked crude lower and pressured energy sentiment ($ABBV, $CL=F). Large 13- and 26-week Treasury bill auctions printed higher coupons, lifting short-end yields and affecting short-duration instruments ($BIL, $SHY).
After Hours — A company press page surfaced near 20:00 ET confirming the AbbVie cash offer details and closing timeline, keeping Apogee takeover spreads in focus ($ABBV, $APGE). No material earnings cluster appeared after the close, leaving the oil-license and bill-auction moves as the dominant post-market drivers ($CL=F, $BIL).
Our Read — Today’s oil-license relief capped energy upside while bigger-than-expected bill yields pushed front-end rates higher. Expect tomorrow’s liquidity and positioning to center on short-end Treasury flows and follow-through in crude pricing.
